Danielle S. Cha, Oksana Kaidanovich-Beilin, and Roger S. McIntyre | Dec 1, 2012 | 10+ min read
Evidence for the role of insulin in mediating normal and abnormal brain function may lead to new treatments for neurological and psychiatric disorders.
The Scientist’s 5th installment of its annual competition attracted submissions from across the life science spectrum. Here are the best and brightest products of the year.
Puerto Rican businesses and residents come together to support the genomic sequencing of the island’s only native parrot species, hoping to help protect the endangered bird.
By tapping local knowledge among African pastoralists and veterinarians, researchers successfully eradicated a deadly livestock virus—and are looking to replicate their success to halt other epidemics.
While exploring the genetics of a rare type of tumor, Stephen Baylin discovered an epigenetic modification that occurs in most every cancer—a finding he’s helping bring to the clinic.
Cell-based assays are popular for high-throughput screens, where they strike a balance between ease of use and similarity to the human body that researchers aim to treat.
